Duchenne Muscular Dystrophy News and Research

RSS
Duchenne muscular dystrophy (DMD) is a progressive muscle disorder that causes the loss of both muscle function and independence. DMD is perhaps the most prevalent of the muscular dystrophies and is the most common lethal genetic disorder diagnosed during childhood today. Each year, approximately 20,000 children worldwide are born with DMD (one of every 3,500 male children).
New drug offers hope for young boys with Duchenne muscular dystrophy

New drug offers hope for young boys with Duchenne muscular dystrophy

Curi Bio Announces Mantarray™ Platform for Analysis of 3D Engineered Muscle Tissues for Discovery of New Therapeutics

Curi Bio Announces Mantarray™ Platform for Analysis of 3D Engineered Muscle Tissues for Discovery of New Therapeutics

Study uncovers a promising new therapeutic approach for Duchenne muscular dystrophy

Study uncovers a promising new therapeutic approach for Duchenne muscular dystrophy

Yale researchers identify possible treatment for Duchenne muscular dystrophy

Yale researchers identify possible treatment for Duchenne muscular dystrophy

Researchers find link between dystrophic muscles and lymphatic system in mice with Duchenne disease

Researchers find link between dystrophic muscles and lymphatic system in mice with Duchenne disease

FDA approves new treatment option for patients with rare Duchenne muscular dystrophy mutation

FDA approves new treatment option for patients with rare Duchenne muscular dystrophy mutation

Heart cell treatment can benefit patients, shows study

Heart cell treatment can benefit patients, shows study

Scientific evidence shows GLDH is a safe biomarker for drug-induced liver injury

Scientific evidence shows GLDH is a safe biomarker for drug-induced liver injury

New editorial published following adverse events of gene therapy clinical trial

New editorial published following adverse events of gene therapy clinical trial

Micro-dystrophin gene therapy can improve outcomes in children with Duchenne muscular dystrophy

Micro-dystrophin gene therapy can improve outcomes in children with Duchenne muscular dystrophy

Antisense Therapeutics: Poster presentation on the Muscular Dystrophy Association Virtual Conference 2020 website

Antisense Therapeutics: Poster presentation on the Muscular Dystrophy Association Virtual Conference 2020 website

UTSW/Children's Health joint program approved as Certified Duchenne Care Center

UTSW/Children's Health joint program approved as Certified Duchenne Care Center

New study indicates novel therapies for Duchenne muscular dystrophy

New study indicates novel therapies for Duchenne muscular dystrophy

Temple researchers reverse muscle fibrosis associated with overuse injury in animals

Temple researchers reverse muscle fibrosis associated with overuse injury in animals

Model that sheds light on severe Duchenne muscular dystrophy could pave the way for new therapies

Model that sheds light on severe Duchenne muscular dystrophy could pave the way for new therapies

New form of gene editing slows ALS progression in mice

New form of gene editing slows ALS progression in mice

Small molecules may open the door to new therapies for Duchenne muscular dystrophy

Small molecules may open the door to new therapies for Duchenne muscular dystrophy

Simple accelerometers improve diagnosis of Duchenne muscular dystrophy

Simple accelerometers improve diagnosis of Duchenne muscular dystrophy

New gene correction therapy for hereditary muscular disease among children

New gene correction therapy for hereditary muscular disease among children

PerkinElmer provides newborn screening assay for PPMD’s New York State pilot program

PerkinElmer provides newborn screening assay for PPMD’s New York State pilot program